InsiderFlow

Benjamin J. Zeskind

IMRX

Benjamin J. Zeskind serves as director, officer: PRESIDENT AND CEO at Immuneering Corporation (IMRX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

7 trades

$254.5K

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$254.5K

Companies Traded

1

IMRX

Active Period

Aug 2021 – Jun 2026

7 total trades

Most Recent

Buy IMRX

Jun 24, 2026 · $10.9K

Benjamin J. Zeskind's Insider Trading at Immuneering Corporation (IMRX)

Buys

7 · $254.5K

Sells

0 · $0.00

Total Shares Bought

60,581

Total Shares Sold

0

IMRX Price Chart
Loading chart...
DateTypeValue
Jun 24, 2026 Buy$10.9K
Jul 1, 2025 Buy$34.9K
Jun 18, 2025 Buy$50.1K
Mar 19, 2024 Buy$55.3K
Mar 24, 2022 Buy$24.1K
Sep 14, 2021 Buy$47.6K
Aug 4, 2021 Buy$31.5K